J&J’s Ethicon acquires Auris Health, Inc

developer of robotic technologies, initially focused on lung cancer, with the FDA approved Monarch Platform robotic technology currently used in bronchoscopic diagnostic and therapeutic procedures.
Ashley McEvoy, EVP, Worldwide Chairman, Medical Devices, Johnson & Johnson, said: “In this new era of health care, we’re aiming to simplify surgery, drive efficiency, reduce complications and improve outcomes for patients, ultimately making surgery safer. We believe the combination of best-in-class robotics, advanced instrumentation and unparalleled end-to-end connectivity will make a meaningful difference in patient outcomes.”
Frederic Moll, CEO and founder of Auris Health will join J&J. He said: “We’re thrilled to be joining Johnson & Johnson to help push the boundaries of what is possible in medical robotics and improve the lives of patients across the globe. Together, we will be able to dramatically accelerate our collective product innovation to develop new interventional solutions that redefine optimal patient outcomes. This combination is a testament to the incredible work of the Auris Health team and the innovation engine behind the Monarch Platform, which represents a huge step forward in endoluminal technology. We look forward to continuing to shape the future of intervention with the added expertise and resources of the world’s largest healthcare organization.”